Low persistence with oral biphosphonate treatment in postmenopausal osteoporosis
Background: Osteoporotic fractures are a major cause of morbidity and mortality. It is recognized that persistence with medication is crucial to reach optimal clinical outcomes. We aimed to estimate the persistence level to weekly and monthly oral bisphosphonates (OBP) in women with postmenopausal o...
Main Authors: | Carla Torre, José Guerreiro, Zilda Mendes, Ana Miranda, Fátima Bragança, Joaquim Cristino, Helena Canhão, Jaime C Branco |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Portuguesa de Reumatologia
2019-04-01
|
Series: | Acta Reumatológica Portuguesa |
Subjects: | |
Online Access: | http://www.actareumatologica.com/files/article/1253_low_persistence_with_oral_biphosphonate_treatment_in_postmenopausal_osteoporosis__file.pdf |
Similar Items
-
Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence
by: Chen M, et al.
Published: (2016-03-01) -
Economic Evaluation of Oral Alendronate Therapy for Osteoporosis in Chinese Postmenopausal Women: The Impact of Medication Compliance and Persistence
by: Ruxu You, et al.
Published: (2020-11-01) -
Effects of COVID-19 Lockdown on Adherence to Individual Home-or Gym-Based Exercise Training among Women with Postmenopausal Osteoporosis
by: Erika Pinelli, et al.
Published: (2021-03-01) -
Ubiquitylomes Analysis of the Whole blood in Postmenopausal Osteoporosis Patients and healthy Postmenopausal Women
by: Yi‐ran Yang, et al.
Published: (2019-12-01) -
Management of postmenopausal osteoporosis
by: Yeap SS, et al.
Published: (2013-10-01)